1. Home
  2. CXAI vs PMN Comparison

CXAI vs PMN Comparison

Compare CXAI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXAI
  • PMN
  • Stock Information
  • Founded
  • CXAI N/A
  • PMN 2004
  • Country
  • CXAI United States
  • PMN Canada
  • Employees
  • CXAI N/A
  • PMN N/A
  • Industry
  • CXAI EDP Services
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • CXAI Technology
  • PMN Health Care
  • Exchange
  • CXAI Nasdaq
  • PMN Nasdaq
  • Market Cap
  • CXAI 33.9M
  • PMN 29.8M
  • IPO Year
  • CXAI N/A
  • PMN N/A
  • Fundamental
  • Price
  • CXAI $1.61
  • PMN $0.95
  • Analyst Decision
  • CXAI
  • PMN
  • Analyst Count
  • CXAI 0
  • PMN 0
  • Target Price
  • CXAI N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • CXAI 882.7K
  • PMN 43.9K
  • Earning Date
  • CXAI 11-12-2024
  • PMN 03-31-2025
  • Dividend Yield
  • CXAI N/A
  • PMN N/A
  • EPS Growth
  • CXAI N/A
  • PMN N/A
  • EPS
  • CXAI N/A
  • PMN N/A
  • Revenue
  • CXAI $7,200,000.00
  • PMN N/A
  • Revenue This Year
  • CXAI $3.86
  • PMN N/A
  • Revenue Next Year
  • CXAI $100.00
  • PMN N/A
  • P/E Ratio
  • CXAI N/A
  • PMN N/A
  • Revenue Growth
  • CXAI N/A
  • PMN N/A
  • 52 Week Low
  • CXAI $1.09
  • PMN $0.87
  • 52 Week High
  • CXAI $7.07
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • CXAI 47.82
  • PMN 52.16
  • Support Level
  • CXAI $1.46
  • PMN $0.88
  • Resistance Level
  • CXAI $1.64
  • PMN $1.03
  • Average True Range (ATR)
  • CXAI 0.10
  • PMN 0.06
  • MACD
  • CXAI 0.01
  • PMN 0.00
  • Stochastic Oscillator
  • CXAI 82.61
  • PMN 46.67

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: